List of Excipients in API neomycin and polymyxin b sulfates and hydrocortisone
Excipients in NDA-approved (novel) drugs containing neomycin and polymyxin b sulfates and hydrocortisone
Excipients in ANDA-approved (generic) drugs containing neomycin and polymyxin b sulfates and hydrocortisone
Detailed excipient profiles for neomycin and polymyxin b sulfates and hydrocortisone
Excipient focus: CETYL ALCOHOL
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing CETYL ALCOHOL
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: CUPRIC SULFATE ANHYDROUS
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing CUPRIC SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing CUPRIC SULFATE ANHYDROUS
Excipient focus: GLYCERIN
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing HYDROCHLORIC ACID
Excipient focus: POLYSORBATE 80
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing POLYSORBATE 80
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM METABISULFITE
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing POTASSIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing POTASSIUM METABISULFITE
Excipient focus: PROPYLENE GLYCOL
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing PROPYLENE GLYCOL
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing SODIUM HYDROXIDE
Excipient focus: SULFURIC ACID
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing SULFURIC ACID
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: THIMEROSAL
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing THIMEROSAL
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing THIMEROSAL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | neomycin and polymyxin b sulfates and hydrocortisone | 0054-0975 |
| Orbicular Pharmaceutical Technologies Private Limited | neomycin and polymyxin b sulfates and hydrocortisone | 81607-014 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
neomycin and polymyxin b sulfates and hydrocortisone drug variants containing WATER
neomycin and polymyxin b sulfates and hydrocortisone drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch